The Effect of Taboo Game-Based Reinforcement on Medication Instruction

July 24, 2026 updated by: Hülya Elmalı Şimşek, Ankara Medipol University

Pharmacology courses are included in nursing curricula, and education on drug knowledge and drug administration is provided in basic nursing courses from the first year of education. However, research shows that students' knowledge of drugs is not at the desired level.

Today, in addition to classical methods, different methods are also used to evaluate information. Game-based approaches are frequently used in nursing for both learning and evaluating information. Escape rooms, digital games, simulation-based games, role-playing, puzzle games, and Kahoot are among the methods used in education . Studies have shown that when gamification is used in education and student evaluation, the recall of information is also at a better level.

This research aims to determine the effect of reinforcing nursing students' knowledge of frequently used medications in emergency departments with the Taboo game and the classic question-and-answer method on learning and information recall.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

111

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being a second-year nursing student
  • Participating in volunteer work
  • Knowing Turkish

Exclusion Criteria:

  • Wanting to quit the job

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Game group
Using the Taboo game as a reinforcer in learning about medications used in the emergency room.
Other: Game
Using taboo game
Active Comparator: Question-and-answer
Using the raditional question-and-answer method as a reinforcer in learning about medications used in the emergency room.
Other: Question-and-answer method
Using the question-and-answer method as reinforcement.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowlegde test results
Time Frame: Baseline
Knowledge Test (included 25 questions)
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowlegde test results and scale results
Time Frame: Test was performed after the second intervention, with the two interventions administered one week apart
Knowledge Test (included 25 questions on 100 points), Gameful Experience Scale (min:27, max:135) (for only game group), Satisfaction Survey with VAS (10 point)
Test was performed after the second intervention, with the two interventions administered one week apart

Other Outcome Measures

Outcome Measure
Time Frame
Knowledge test (Follow-up test)
Time Frame: A retention test was performed one month after the second intervention, with the two interventions administered one week apart
A retention test was performed one month after the second intervention, with the two interventions administered one week apart

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ankara Medipol University

Collaborators

Siirt University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 2, 2026

Primary Completion (Actual)

April 17, 2026

Study Completion (Actual)

June 17, 2026

Study Registration Dates

First Submitted

February 27, 2026

First Submitted That Met QC Criteria

July 24, 2026

First Posted (Actual)

July 27, 2026

Study Record Updates

Last Update Posted (Actual)

July 27, 2026

Last Update Submitted That Met QC Criteria

July 24, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 1662258

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on No Medical Condition

Clinical Trials on Game

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe